STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

Active, not recruiting

Brief Summary: The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.

Detailed Description: The investigators aim to optimize implementation of opportunistic salpingectomy throughout the Netherlands. The investigators will evaluate the implementation by enrolling patients in a database to evaluate healthcare experiences and to register EOC diagnosis and vital status through yearly PALGA (the nationwide network and registry of histopathology and cytopathology in the Netherlands) and municipal administration searches. In addition, the investigators will perform medical record check to assess which percentage of eligible women have been offered OS.

The investigators expect that a decision aid will be a necessary tool for the decision whether women opt for an OS or not, based on their personal values. After development of the tool(s), the investigators will evaluate the implementation process.

Recruitment & Eligibility

Inclusion Criteria

Age from 30 years
Undergoing gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved
Childbearing completed
Able to understand the written or spoken Dutch language
Consent for enrolment in database
Consent for yearly checks of PALGA database and municipal administration

Exclusion Criteria

Arm && Interventions

Group	Intervention	Description
Choice for Opportunistic Salpingectomy	Opportunistic Salpingectomy	Women who will undergo a gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved, can opt for an opportunistic salpingectomy.

Primary Outcome Measures

Name	Time	Method
Offered Opportunistic Salpingectomy (OS)	2019 - 2023	Number of eligible women who have actually been offered an opportunistic salpingectomy in the Netherlands.
Implementation effect of Opportunistic Salpingectomy (OS)	2019-2023	The effect of our implementation efforts on the number of eligible women who have actually been offered an opportunistic salpingectomy in the Netherlands.

Secondary Outcome Measures

Name	Time	Method
Influencing factors implementation Opportunistic Salpingectomy (OS)	2019-2020	Determine factors that impede and facilitate nationwide implementation of Opportunistic Salpingectomy.
Implementation tools	2019-2020	Implementation tools, developed based on the barriers and facilitators of the influencing factors.

Locations (27): Erasmus Medical Center
🇳🇱
Rotterdam, Netherlands
Elisabeth-Tweesteden Hospital
🇳🇱
Tilburg, Netherlands
Diakonessenhuis
🇳🇱
Utrecht, Netherlands
Maxima Medical Center
🇳🇱
Veldhoven, Netherlands
OLVG
🇳🇱
Amsterdam, Netherlands
Slingeland Hospital
🇳🇱
Doetinchem, Netherlands
Academic Medical Centrum
🇳🇱
Amsterdam, Netherlands
Amphia hospital
🇳🇱
Breda, Netherlands
Rijnstate Hospital
🇳🇱
Arnhem, Netherlands
Reinier de Graaf
🇳🇱
Delft, Netherlands
Haaglanden Medical Center Westeinde
🇳🇱
Den Haag, Netherlands
Medical Spectrum Twente
🇳🇱
Enschede, Netherlands
Ziekenhuisgroep Twente
🇳🇱
Hengelo, Netherlands
Isala
🇳🇱
Zwolle, Netherlands
Spaarne Gasthuis
🇳🇱
Haarlem, Netherlands
Medical Center Leewarden
🇳🇱
Leeuwarden, Netherlands
Leids University Medical Center
🇳🇱
Leiden, Netherlands
Maastricht University Medical Center
🇳🇱
Maastricht, Netherlands
Radboud UMC
🇳🇱
Nijmegen, Netherlands
Canisius Wilhelmina Hospital
🇳🇱
Nijmegen, Netherlands
VieCuri Medical Center
🇳🇱
Venlo, Netherlands
Sint Jans Gasthuis
🇳🇱
Weert, Netherlands
Jeroen Bosch Hospital
🇳🇱
's-Hertogenbosch, Netherlands
Albert Schweitzer hospital
🇳🇱
Dordrecht, Netherlands
Catharina Hospital
🇳🇱
Eindhoven, Netherlands
Martini hospital
🇳🇱
Groningen, Netherlands
St Antonius
🇳🇱
Nieuwegein, Netherlands